belimumab 400 MG Injection

RxCUI
1656400
RxNorm name
belimumab 400 MG Injection
Display name
belimumab 400 MG Injection
Full name
belimumab 400 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761043Benlystabelimumab351(a)Rx2026-06-01
125370Benlystabelimumab351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BENLYSTABELIMUMABGlaxoSmithKline LLC2fa3c528-1777-4628-8a55-a69dae2381a32025-06-20Warnings, Adverse reactionsExact identifier
rxcui: 1656400

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2fa3c528-1777-4628-8a55-a69dae2381a3belimumab 400 MG InjectionSCD37These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 201120250620
2fa3c528-1777-4628-8a55-a69dae2381a3belimumab 400 MG InjectionPSN37These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 201120250620